08 {{ "2026-01-08T00:00:00+00:00" | date "MMM" }} '26

Written on {{ "2026-01-08T00:00:00+00:00" | date "longDate" }}

Bayer News

Bayer, Cradle Collaborate on AI-Driven Antibody Engineering

The three-year partnership integrates Cradle’s protein engineering AI into Bayer’s R&D workflows to improve lead optimization efficiency, developability, and scalability in biologics discovery.

Read more…

07 {{ "2026-01-07T00:00:00+00:00" | date "MMM" }} '26

Written on {{ "2026-01-07T00:00:00+00:00" | date "longDate" }}

GE HealthCare News

Edge AI for Real-Time Clinical Decision Support

NXP Semiconductors N.V. and GE HealthCare are collaborating to apply secure, low-latency edge AI to acute care devices, with new concepts.

Read more…

06 {{ "2026-01-06T00:00:00+00:00" | date "MMM" }} '26

Written on {{ "2026-01-06T00:00:00+00:00" | date "longDate" }}

Aetina

Aetina Introduces AIB-AT Serie for Physical AI and Robotics

The new AIB-AT platforms expand Aetina’s DeviceEdge portfolio with high-performance, low-latency computing designed for industrial robotics and emerging physical AI applications.

Read more…

30 {{ "2025-12-30T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-12-30T00:00:00+00:00" | date "longDate" }}

Johnson & Johnson News

Johnson & Johnson Advances Cancer Treatment Through Halda Therapeutics Acquisition

The acquisition adds a clinical-stage prostate cancer therapy and a novel RIPTAC platform aimed at improving precision targeting and overcoming treatment resistance in solid tumors.

Read more…

29 {{ "2025-12-29T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-12-29T00:00:00+00:00" | date "longDate" }}

Johnson & Johnson News

Johnson & Johnson Halts DUPLEX-AD Atopic Dermatitis Study Early

Johnson & Johnson terminated its Phase 2b trial for JNJ-5939 after an interim analysis showed the drug failed to meet high-bar efficacy standards for treatment.

Read more…

27 {{ "2025-12-27T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-12-27T00:00:00+00:00" | date "longDate" }}

Novo Nordisk News

First Oral GLP-1 Pill for Obesity Gains FDA Approval

Novo Nordisk’s regulatory validation of a once-daily oral semaglutide expands weight-management options in metabolic care and cardiovascular risk reduction.

Read more…

26 {{ "2025-12-26T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-12-26T00:00:00+00:00" | date "longDate" }}

Dassault Systemes News

AI Virtual Twins for Alzheimer’s Care

Dassault Systèmes presents an immersive AI-driven virtual twin experience at CES 2026, highlighting new approaches to dementia and Alzheimer’s research, diagnosis, and care.

Read more…

23 {{ "2025-12-23T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-12-23T00:00:00+00:00" | date "longDate" }}

Bayer News

Finerenone Approved in Japan for Chronic Heart Failure Treatment, reports Bayer

Japan’s health regulator has approved finerenone for adults with chronic heart failure and left ventricular ejection fraction of at least 40%, expanding pharmacological options for a large, underserved patient population.

Read more…

19 {{ "2025-12-19T00:00:00+00:00" | date "MMM" }} '25

Written on {{ "2025-12-19T00:00:00+00:00" | date "longDate" }}

OGP

OGP Appoints Panos Angelopoulos as President of Global Sales

Veteran manufacturing executive succeeds Stephen Flynn, supporting OGP’s next phase of global growth.

Read more…